| 37224871 | Understanding of and clinical approach to cardiometabolic transition at the menopause. | | 2023 |
| 36302338 | The effect of menopause on lipoprotein (a) concentrations: A systematic review and meta-analysis. | | 2023 |
| 36327019 | Screening and management of major endocrinopathies during pregnancy: an update. | Endocrine | 2023 |
| 37671810 | The severity of menopausal symptoms is associated with diabetes, and cardiometabolic risk factors in middle-aged women. | | 2023 |
| 37845136 | EMAS position statement: Testosterone replacement therapy in older men. | | 2023 |
| 37597095 | Site specific differences in vBMD and geometry in postmenopausal women with primary hyperparathyroidism. | | 2023 |
| 37798604 | Efficacy and safety of metformin during pregnancy: an update. | | 2023 |
| 38048636 | Sexual function scores are associated with arterial stiffness in postmenopausal women. | | 2023 |
| 36968684 | Human Leukocyte Antigen Alleles Compatibility and Immunophenotypic Profile Associations in Infertile Couples. | | 2023 |
| 36907116 | Vasomotor symptoms and risk of cardiovascular disease in peri- and postmenopausal women: A systematic review and meta-analysis. | | 2023 |
| 36769563 | Vitamin D, Menopausal Health and COVID-19: Critical Appraisal of Current Data. | | 2023 |
| 36763958 | Climacteric symptoms, age, and sense of coherence are associated with sexual function scores in women after menopause. | | 2023 |
| 36566517 | EMAS position statement: Vitamin D and menopausal health. | | 2023 |
| 37130378 | Early menopause and cardiovascular risk factors: a cross-sectional and longitudinal study. | | 2023 |
| 36805072 | Implementation of risk enhancers in ASCVD risk estimation and hypolipidemic treatment eligibility: A sex-specific analysis. | | 2023 |
| 36621415 | Depression after menopause and the use of menopausal hormone therapy. | | 2023 |
| 35303270 | Non-alcoholic fatty liver disease through the female lifespan: the role of sex hormones. | Journal of Endocrinological Investigation | 2022 |
| 35525259 | Menopause: a cardiometabolic transition. | Lancet Diabetes and Endocrinology,The | 2022 |
| 36104976 | Daughters of polycystic ovary syndrome pregnancies and androgen levels in puberty: a Meta-analysis. | Gynecological Endocrinology | 2022 |
| 36038695 | Dietary patterns are associated with arterial stiffness and carotid atherosclerosis in postmenopausal women. | Endocrine | 2022 |
| 35569270 | Menopause, wellbeing and health: A care pathway from the European Menopause and Andropause Society. | | 2022 |
| 35377481 | Does reproductive stage impact cardiovascular disease risk factors? Results from a population-based cohort in Lausanne (CoLaus study). | Clin Endocrinol (Oxf) | 2022 |
| 35798847 | The interplay between diabetes mellitus and menopause: clinical implications. | Nature Reviews Endocrinology | 2022 |
| 36325501 | Menopause, androgens, and cardiovascular ageing: a narrative review. | Therapeutic Advances in Endocrinology and Metabolism | 2022 |
| 35532850 | Menopausal hormone therapy in women with dyslipidemia and nonalcoholic fatty liver disease. | Hormones | 2022 |
| 34015467 | Serum prolactin levels interact with menstrual fluctuations of arterial stiffness. | Hellenic Journal of Cardiology | 2022 |
| 34862111 | Menstrual irregularity and bone health in premenopausal women: Are oral contraceptives the best option? | | 2022 |
| 35258483 | Menopause-associated risk of cardiovascular disease. | Endocrine Connections | 2022 |
| 35216409 | GnRH Analogues as a Co-Treatment to Therapy in Women of Reproductive Age with Cancer and Fertility Preservation. | International Journal of Molecular Sciences | 2022 |
| 35163560 | Bone Health in Patients with Dyslipidemias: An Underestimated Aspect. | International Journal of Molecular Sciences | 2022 |
| 35115178 | The essential menopause curriculum for healthcare professionals: A European Menopause and Andropause Society (EMAS) position statement. | Maturitas | 2022 |
| 34601490 | Prediction of insulin treatment in women with gestational diabetes mellitus. | Nutrition and Diabetes | 2021 |
| 33754212 | Assessing the efficacy of a structured stress management program in reducing stress and climacteric symptoms in peri- and postmenopausal women. | Archives of Women's Mental Health | 2021 |
| 33541565 | Updates on the treatment of invasive breast cancer: Quo Vadimus? | | 2021 |
| 34169795 | Cardiometabolic health in premature ovarian insufficiency. | Climacteric | 2021 |
| 33896654 | Topical estrogens and non-hormonal preparations for postmenopausal vulvovaginal atrophy: An EMAS clinical guide. | | 2021 |
| 33739315 | Genitourinary syndrome of menopause: a systematic review on prevalence and treatment. | Menopause | 2021 |
| 34274232 | Hormone therapy regimens for managing the menopause and premature ovarian insufficiency. | | 2021 |
| 34274202 | Global consensus recommendations on menopause in the workplace: A European Menopause and Andropause Society (EMAS) position statement. | Maturitas | 2021 |
| 33451805 | Premature ovarian insufficiency: A toolkit for the primary care physician. | | 2021 |
| 33508999 | MTHFR Polymorphisms in Girls with Anorexia Nervosa: Implications on Body Weight. | Endocrine Research | 2021 |
| 33495787 | Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists, gynaecologists, and endocrinologists. | European Heart Journal | 2021 |
| 33202443 | Circulating Amyloid Beta 1-40 Is Associated with Increased Rate of Progression of Atherosclerosis in Menopause: A Prospective Cohort Study. | Thrombosis and Haemostasis | 2021 |
| 32519298 | Estrogen and bones after menopause: a reappraisal of data and future perspectives. | Hormones | 2021 |
| 33294389 | Menopausal hormone therapy and breast cancer risk: All progestogens are not the same. | Case Reports in Women's Health | 2021 |
| 33008675 | Management of urinary incontinence in postmenopausal women: An EMAS clinical guide. | | 2021 |
| 33399077 | How we treat endocrine complications of immune checkpoint inhibitors. | ESMO Open | 2021 |
| 33434082 | Premature ovarian insufficiency: a toolkit for the primary care physician. | Climacteric | 2021 |
| 34794893 | Hormone therapy for menopause and premature ovarian insufficiency. | | 2021 |
| 34625915 | Obesity, metabolic syndrome, and cancer: pathophysiological and therapeutic associations. | Endocrine | 2021 |